Autifony Therapeutics Limited   Report issue

For profit Phase 1 Phase 2
Founded: London United Kingdom (2011)

Organization Overview

First Clinical Trial
2014
NCT02315508
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Autifony Therapeutics Limited